|
April 27, 2000
Books
Columnists
Indian Tax
Insurance
Interview
Mutual Funds
NRI Tax
Personal Finance
Personal Banking
Real Estate
Stocks
|
| Smithkline Beecham Pharma MQ 2000 Net profit slides 50%, sales down by 23% |
| Smithkline Beecham Pharmaceuticals (India) Ltd has announced a net profit of Rs 39.77 million for the quarter ended March 31, 2000 as against Rs 79.65 million in MQ 99. The sales and service income are down by 2.61 % at Rs 680.52 million (MQ 99 Rs 879.29 million). Other income is Rs 224.08 million (MQ 99 Rs 19.88 million). The interest charges for the quarter is lower by 67.25% at Rs 2.24 lacs as against Rs 6.8 lacs in MQ 99. The provision for taxation is also substantially lower at Rs 12.50 million as compared to Rs 23.50 million in MQ 99. |
| Henkel Spic MQ 2000 net profit at Rs 7.82 million, Turnover rises 70 % |
| Henkel Spic India Ltd has recorded a net profit of Rs 7.82 million for the quarter ended March 31, 2000 as against a loss of Rs 6.36 million incurred in MQ 99. The sales are up by 69.70 % at Rs 750.24 million. Other income is Rs 5.07 million (MQ 99 Rs 6.058 million). The gross profit for the quarter is Rs 61.67 million as compared to Rs 46.80 million in MQ 99, an increase of 31.77 %. |
| PSI Data net profit increases 122 %, sales up by 66 % |
| PSI Data Systems Ltd has reported a net profit of Rs 39.90 million for the quarter ended March 31, 2000 as against Rs 18.01 million in MQ 99. The sales are up by 66.10 % at Rs 182.87 million. Other income is Rs 1.85 million (MQ 99 Rs 0.80 million). The PBT is 116.65 % higher at Rs 44.66 million over MQ 99 figures of Rs 20.61 million. The interest expenses have dropped considerably from Rs 1.58 million in MQ 99 to Rs 66 thousand in MQ 2000. The company has reported a EPS of Rs 5.27 on a equity share capital of Rs 75.50 million. |
| SSI Ltd MQ 2000 Net profit rises 150%, turnover up by 138% |
| SSI Ltd has announced a net profit of Rs 105.03 million for the quarter ended March 31, 2000 as against Rs 42.02 million in MQ 99. The incomes from operations are up by 137.84 % at Rs 532.77 million. The company has reported that the entire income from operations represent income related to software business. Other income is Rs 5.03 million (MQ 99 Rs 9.63 million). PBDIT for the quarter ended March 31, 2000 is Rs 177.47 million (MQ 99 Rs 88.96 million). The interest charges for the quarter were Rs 9.59 million, 33.64% lower than interest expense incurred in MQ 99 (Rs 14.46 million). Depreciation for MQ 2000 was Rs 39.84 million (Rs 15.43 million in MQ 99). |
| Cipla net profit up 15% at Rs 1318 million, turnover rise 23.04% |
| Cipla Ltd has recorded a net profit of Rs 1318 million for the year ended March 31, 2000 as against Rs 1149.50 million in FY 99. The sales are up by % at Rs 7593.40 million. Other income is Rs 311.60 million (FY 99 Rs 265.60 million). The equity capital of the company is Rs 599.70 million after it allotted Bonus shares on Decmber 10, 1999. The profits for the quarter ended March 31, 2000 are Rs 290.80 million, as compared to Rs 259.70 million in the previous financial year. The sales for the quarter are 31.35 % up at Rs 1721million as against Rs 1310.20 million in the MQ 99. |
| Bayer Diagnostics net profit at Rs. 6.18 million for MQ 2000, turnover up 44.55% |
| Bayer Diagnostics Ltd posted a net profit of Rs. 6.18 million for the quarter ended March 31, 2000 as against Rs. 6/- million in MQ 99. The sales are up by 44.55% at Rs 88.50 million for the quarter ended March 31, 2000 as against Rs. 61.22 million in MQ 99. Other income is Rs 0.74 million (MQ 99 Rs 0.95 million). On a paid up equity share capital of Rs. 15.68 million, the EPS increased from Rs. 3.38(MQ 99) to Rs. 3.94 in MQ 2000. |
| Hind Lever Chemicals net rises 92.71%, Turnover up by 16.94 % |
| Hind Lever Chemicals Ltd has reported a turnover of Rs 2366.20 million for the quarter first quarter ended March 31, 2000 as compared to Rs 2023.50 million achieved in MQ 99, an increase of 16.94%. IN the first quarter the PBDIT increased to Rs 171.90 million (MQ 99 Rs 90 million) while the PBT stood at Rs 102.40 million (MQ 99 Rs 53.60 million). The PBT includes Rs 51 million being the differential amount of price concession for the period Rabi 1998-99, for which the final rates of price concession were announced by the Government of India on March 7, 2000. The profit after tax increased to Rs 81.90 million as against Rs 42.50 million in MQ 99. |
| Hoganas Board to consider bonus issue and final dividend on May 23 |
| The Board of Directors of Hoganas India Ltd will meet on May 23, 2000 to consider the bonus issue and the final dividend for the year 1999-2000. |
| Ind-Swift net profit up by 111.60% in MQ 2000, turnover rises 41% |
Ind-Swift Ltd registered a net profit growth of 111.60% at Rs 17.09 million for the quarter ended March 31, 2000 as against Rs. 8.08 million in MQ 99. The income from operations are up by 40.83 % at Rs 193.79 million (MQ 99 Rs. 137.61million). Other income for the quarter ended March 31,2000 is Rs 2.02 million (MQ 99 Rs 0.72 million). The profits for the year ended March 31, 2000 are Rs 57.67 million, as compared to Rs 32.51million in the previous financial year, an increase of 77.39%. The annual sales are 22.73 % higher at Rs Rs. 761.64 million as against Rs. 621.92 million in the financial year ending March 1999.
The company's new plant at Parwanoo in Himachal Pradesh has commenced commercial production in April this year. Ind-Swift expects an additional turnover of Rs. 300 million from this new unit during the financial year.
The company has recently launched a Super Speciality Division, for introducing drugs based on NDDS, the results of which will be reflected in the next quarter's performance.
|
| Widia India recommends 1:1 bonus share, declares second interim of 15% |
Widia (India) Ltd reported a net profit of Rs 6.15 million for the quarter ended March 31, 2000 as against Rs. 2.25 million in MQ 99, a growth of 173.33%. The sales are up by 17.22% at Rs 352.82 million (MQ 99 Rs. 301.00 million). Other income is Rs. 0.67million (MQ 99 Rs 1.93 million).
At a board meeting held on April 27, 2000, the Directors recommended an issue of one bonus share for every equity share held as on a date to be fixed later by the Board. The Board also declared a second interim dividend of 15% for the year 1999. The Board has fixed May 16, 2000 as the Record Date for the purpose of second interim dividend.
|
| Foseco India records net loss of Rs. 8.52 million for MQ 2000 |
Foseco India Ltd reported a net loss of Rs 8.52 million for the quarter ended March 31, 2000 as against a profit of Rs.7.21million in MQ 99. The sales are lower by 4.04 % at Rs 195.85 million as against Rs. 204.10 million in MQ 99. Other income is Rs 3.52 million (MQ 99 Rs 0.41million). The results include extraordinary expenses of Rs. 35.22 million, including interest of Rs. 10.49 million on the term loan, arising from the ongoing Project Navodaya business transformation programme. The corresponding expenses for the previous year's quarter ended on March 31, 1999 were Rs. 26.87 million and included interest of Rs. 7.33 million.
The company has restructured its activities relating to its steel division business at the TISCO site, Jamshedpur from April 1, 2000 and has announced a VRS on April 10, 2000 for its employees at that site. Further, the company has announced a VRS on April 10, 2000 for employees at various locations of its steel division. The costs of both the VRS programmes will be amortised beginning from the second quarter of the year 2000.
|
| Ranbaxy to consider stock-options for employees |
| At the Board Meeting of Ranbaxy Laboratories Ltd to be held on April 29, 2000 for considering the financial results, the Directors would also consider an Employees Stock Option Scheme. |
| Krone Communications net profit up 58.58% in MQ 2000 |
| At a board meeting held on April 27, 2000, Krone Communications Ltd reported a growth of 58.58 % in net profit at Rs 42.50 million for the quarter ended March 31, 2000 as against Rs. 26.80 million in MQ 99. The sales are up by 33.61% at Rs 226.20 million compared to Rs. 169.30 million in MQ 99. Other income is Rs 2.90 million (MQ 99 Rs 3.80 million). |
| TTK Biomed net profit up by 209.44% for MQ 2000 |
TTK Biomed Ltd has reported a net profit growth of 209.44% at Rs 13.87 million for the quarter ended March 31, 2000 as against a loss of Rs. 12.68 million in MQ 99. The sales are up by 111.14 % at Rs 36.71 million. Other income is Rs 0.04 million (MQ 99 Rs 0.75 million).
The shareholders of TTK Biomed Ltd and TTK Healthcare Ltd have unanimously approved the scheme of Amalgamation between the two companies and replies have been filed before the High Court for sanction of the Scheme.
|
| Tata Finance net profit at Rs. 189.52 million for MQ 2000 |
| At a meeting of its Board of Directors on April 26, 2000, Tata Finance Ltd reported a net profit growth of 1111.99% at Rs189.52 million for the quarter ended March 31, 2000 as against Rs 15.64 million in MQ 99. (Profits have been arrived at, after complying with the prudential norms for Income recognition and provisioning for doubtful debts on Non-performing assets issued by the Reserve Bank of India). The income from operations are at Rs 1118.59 million for the quarter ended March 31, 2000 as against Rs. 1349.54 million in MQ 99. Other income is Rs 511.94 million for MQ 2000 (MQ 99 Rs 235.26 million) |
RISC
Tell us what you think of this feature
|
